TrialDiabetes technology & therapeutics2013

Nateglinide and acarbose are comparably effective reducers of postprandial glycemic excursions in chinese antihyperglycemic agent-naive subjects with type 2 diabetes.

Jian Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.